Skip to search formSkip to main contentSkip to account menu

Vercyte

Known as: Abbott Brand of Pipobroman 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pipobroman

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association
We report here a 71 year-old female presenting with acute myeloblastic leukemia (FAB-M1) after treatment of essential… 
Review
1994
Review
1994
Is a clinical consensus possible for the polycythaemic patients?
No conference of consensus was previously held in France, in the field of hematology. We decided to study the polycythemias… 
1972
1972
[Vercyte in the therapy of polycythemia].
1969
1969
[Results of the treatment of polycythemia vera with Vercyte].
1967
1967
Evaluation of two antineoplastic agents, PIPOBROMAN (vercyte) and thioguanine.
  • Journal of the American Medical Association (JAMA…
  • 1967
  • Corpus ID: 11654821
1967
1967
The treatment of lepromatous leprosy and erythema nodosum leprosum with the cytostatic drugs Ancyte and Vercyte.
1967
1967
Pipobroman (Vercyte) - a new antineoplastic drug.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)